Rekombinanter CD52 (Alemtuzumab Biosimilar) Antikörper

Produktnummer ABIN7795101

Der Maus Monoklonal Anti-CD52 (Alemtuzumab Biosimilar) Antikörper wurde für FACS und in vivo validiert. Er ist geeignet, CD52 (Alemtuzumab Biosimilar) in Proben von Human zu detektieren.

Kurzübersicht für Rekombinanter CD52 (Alemtuzumab Biosimilar) Antikörper (ABIN7795101)

Target: CD52 (Alemtuzumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD52 (Alemtuzumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-CD52 (Alemtuzumab Biosimilar) Antikörper

Expressionssystem: Mammalian cells

Verwendungszweck: Alemtuzumab Biosimilar, Human CD52 Monoclonal Antibody

Produktmerkmale: Alemtuzumab Biosimilar uses the same protein sequences as the therapeutic antibody alemtuzumab. Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is given by injection into a vein. It is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. After treatment with alemtuzumab, these CD52-bearing lymphocytes are targeted for destruction.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human CD52

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Details zu CD52 (Alemtuzumab Biosimilar)

Target: CD52 (Alemtuzumab Biosimilar)

Andere Bezeichnung: Alemtuzumab Biosimilar

Substanzklasse: Biosimilar